Die neue Leitlinie unterstreicht den Nutzen nichtinvasiver Tests für die Einstufung und die Behandlung fortgeschrittener Lebererkrankungen PARIS und WESTBOROUGH (Massachusetts), 11. November 2023 /PRNewswire/ — Die American Association for the Study of Liver Disease (AASLD) hat neue…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.